In-vitro antibacterial activity of omeprazole and esomeprazole in combination with ciprofloxacin as an alternative to repositioning against ESKAPE pathogens and evaluation of the cleavage capacity of plasmid DNA.

Taciéli F da Rosa Vitória S Foletto Marissa B Serafin Bruno R de Paula Laísa N Franco Sara de L Marion Augusto D da Mota Rosmari Hörner

Int J Antimicrob Agents

Laboratory of Bacteriology, Health Sciences Center, Federal University of Santa Maria, Santa Maria, RS, Brazil; Department of Clinical and Toxicological Analysis, Health Sciences Center, Federal University of Santa Maria, Santa Maria, RS, Brazil. Electronic address:

Published: May 2023

Download full-text PDF	Source
http://dx.doi.org/10.1016/j.ijantimicag.2023.106753	DOI Listing

Publication Analysis

Top Keywords

in-vitro antibacterial

antibacterial activity

activity omeprazole

omeprazole esomeprazole

esomeprazole combination

combination ciprofloxacin

ciprofloxacin alternative

alternative repositioning

repositioning eskape

eskape pathogens

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!